Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to bring affordable hearing help to korean american seniors

NCT ID NCT06803394

Symptom relief Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a hearing care program for older Korean Americans (age 60+) who have hearing loss but do not use hearing aids. The program includes a low-cost sound amplifier and communication training, delivered in the community. Researchers will compare participants who get the program right away to those who wait 6 months, measuring changes in hearing handicap and quality of life for both the participants and their communication partners.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
K-HEARS intervention (aural rehabilitation and personal sound amplifier)
What this could lead to
If successful, this could provide an affordable, accessible way to improve hearing and communication for older Korean Americans, reducing hearing handicap and improving quality of life.
What could go wrong
This is a behavioral and device study, not a medical treatment. Results may not apply to other groups, and the benefits may be modest or not sustained long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

PARTICIPANT CRITERIA Participant inclusion criteria * Self-identified as first-generation KA in the target region * Age 60 years or older * Has a communication partner who lives in the same household or has at least weekly interactions * Screening audiometry Pure-tone audiometry (PTA)1,2,4 kilohertz (kHz) \>25 decibel (dB) hearing loss (HL) in better ear * Hearing handicap as measured by HHIE-S score \>=8 Participant exclusion criteria * Current use of hearing aid * Medical contraindications to use amplification device (e.g., draining ear) * Plan to move from the area within 6 months * Active treatment for a terminal illness or in hospice COMMUNICATION PARTNER CRITERIA Communication Partner inclusion criteria * Age 18 years or older * Able to read and speak Korean * Lives with the older adult or has at least weekly interactions Communication Partner exclusion criteria * Plan to move from the area within 6 months * Active treatment for a terminal illness or in hospice

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Age-related hearing impairment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Communication hearing loss disorder presbycusis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Age-related hearing impairment Community-dwelling seniors Hearing impairment Hearing loss KOREAN Personal communication

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Johns Hopkins School of Nursing

    Baltimore, Maryland, 21205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.